Kaiser Can Pursue Monopoly Claims Against Abbott Over Hytrin - Bloomberg.com

Links shared publicly online about this topic.

  • 2,332
    total visits

Kaiser Can Pursue Monopoly Claims Against Abbott Over Hytrin - Bloomberg.com

bloomberg.com —

A unit of Kaiser Permanente, the largest U.S. nonprofit health maintenance organization, can pursue claims that [bn:WBTKR=ABT:US] Abbott Laboratories [] maintained an unlawful monopoly over its hypertension treatment Hytrin.

View full resource at bloomberg.com

Tags: Heart Disease, High Blood Pressure, Benign Prostatic Hypertrophy Medication, Health Insurance, Hytrin, Abbott Laboratories, Kaiser Permanente

  • Share

Most Recently Shared on January 14, 2009 at 5:28 pm By:

Q1Productions Q1 Productions

Kaiser Can Pursue Monopoly Claims Against Abbott Over Hytrin http://tinyurl.com/8dfz7b

3 years ago...

Reply

Retweet

Favorite

Advertisement